US.TMO · Thermo Fisher Scientific

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.8,
      "details": {
        "atrPct": 2.9175942028985506,
        "turnoverUsdM": 1453.485,
        "liquidityPoints": 0.8,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.TMO",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 649.7372,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 5.8,
      "take_profit_price": 739.7246,
      "target_multiplier": 1.9,
      "technical_strength": 1.95,
      "take_profit_percent": 7.2
    },
    "positionPoints": 1.8,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2338933208818066,
    "stopLossPercent": 5.835188405797101,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 68,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 668.3455,
    "ma50": 636.689,
    "close": 690,
    "prevClose": 696.49,
    "avgVolume20": 2208725,
    "volumeRatio": 0.95,
    "changePercent": -0.93
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": 0.048600314622646135,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 0.9031566536255963,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.8111297630266122,
      "volat_points": 0,
      "day_range_pct": 0.022565231884058005,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 68,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 7,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 46.67,
        "contribution": 7
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 70,
        "contribution": 7
      },
      {
        "raw": 21.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 71.67,
        "contribution": 21.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 7/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7/10分",
      "技術信號分析總分: 21.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 15.6,
      "市場環境": 7,
      "情緒分析": 4,
      "技術信號": 21.5,
      "風險管理": 7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 1453.485,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 3.2,
          "obvPoints": 3.2,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TMO",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.46
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 742.51900315,
                "ma50": 726.7734006600002,
                "name": "QQQ",
                "close": 709.79999,
                "points": 0.4
              },
              "spy": {
                "ma20": 771.1839966499999,
                "ma50": 768.5017965800001,
                "name": "SPY",
                "close": 763.25,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.9175942028985506,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142957868,
                "url": "https://finnhub.io/api/news?id=41edded3ed342441d5de01bda70b447dd724e8160e14a0cd36b2a8a68ebdcc60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology diagnostics, according to recent industry reports. Sector intelligence points to the group as a key provider of targeted omics and biomarker analytics solutions for precision medicine-focused projects. Reports also highlight Thermo Fisher's role in immuno-oncology diagnostic workflows that support more tailored cancer treatment decisions. Thermo Fisher's push into proteomic...",
                "category": "company",
                "datetime": 1792207248,
                "headline": "Thermo Fisher Scientific (TMO) Is Building A Bigger Role In Precision Diagnostics"
              },
              {
                "id": 142950878,
                "url": "https://finnhub.io/api/news?id=01a659179e977f99d551871332a195383d76d25b6bef1ad7ef5128a3afd70cb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific’s fair value estimate has shifted from US$652.85 to US$686.64, pointing to a modestly higher price target in current models. Recent analyst commentary ties this change to more supportive views on Q2 results, sector demand trends and updated company guidance, even as opinions remain split between bullish and more cautious takes. As you read on, you will see how this evolving narrative fits together and what to watch next as new research comes out. Analyst Price Targets...",
                "category": "company",
                "datetime": 1792185336,
                "headline": "Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target Increases"
              },
              {
                "id": 142948029,
                "url": "https://finnhub.io/api/news?id=b3744e5e387099b071930da9d9246cbd89a20d5f498d066719144ef65eb38e73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q3 2026 investor letter for the “Focused Equity Strategy.” The letter can be downloaded here. The Focused Equity Strategy returned 8.9% gross and 8.7% net in Q3, amid a dynamic investment environment driven by AI infrastructure development. Following an initial […]",
                "category": "company",
                "datetime": 1792164465,
                "headline": "Academic and Government Spending Powers Thermo Fisher (TMO)"
              },
              {
                "id": 142945657,
                "url": "https://finnhub.io/api/news?id=86e42f84449ed54ac215737cb78e9d174bc58dfa04180f23896b357ead3b8403",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Thermo Fisher (TMO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.",
                "category": "company",
                "datetime": 1792152926,
                "headline": "What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings"
              },
              {
                "id": 142885249,
                "url": "https://finnhub.io/api/news?id=57b213eed712c316f4e53ea07da5debb1bd5815da8cff9d3337868093a8277d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1791982813,
                "headline": "Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 142848795,
                "url": "https://finnhub.io/api/news?id=e2aa27bd6760faf5c356ce5abfd9734842cec4cbe5d04868e16d93989348647e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Lindsell Train Ltd, an investment management company, has released its “Lindsell Train Global Equity Fund” third-quarter 2026 investor letter. The letter can be downloaded here. To drive long-term capital growth, the LT Global Equity Fund maintains a concentrated portfolio of developed-market global equities. The Fund fell 1.4% in Q3 2026, trailing the MSCI World Index […]",
                "category": "company",
                "datetime": 1791899665,
                "headline": "Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth"
              },
              {
                "id": 142848796,
                "url": "https://finnhub.io/api/news?id=75e139aed4770546b0a8239bdcbf52cb2262d5fe8b034413dcc8194c6f4c4553",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Earlier this month, Quantum BioPharma announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to implement a Phase 2 trial of Lucid-MS in progressive multiple sclerosis, while Thermo Fisher also unveiled new drug development, manufacturing, and evidence-generation solutions at CPHI Milan 2026. These developments highlight Thermo Fisher’s widening role across the drug lifecycle, from complex clinical trials to advanced bioprocessing, cell culture media,...",
                "category": "company",
                "datetime": 1791893773,
                "headline": "Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO)"
              },
              {
                "id": 142847531,
                "url": "https://finnhub.io/api/news?id=5cfb9dfdea22a5616bda9ba5452120ce1fd0d290e0b159c54bde33664ca63ea8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has delivered a solid share price run in recent years, which puts a spotlight on whether the current US$662.24 level lines up with the cash it can generate over time. With fresh partnerships and industry collaborations in play, the key consideration is how much of that future cash flow story is already built into the stock. Thermo Fisher Scientific has returned 36.9% over the past 3 years, so a meaningful part of the long term investment case now hinges on whether...",
                "category": "company",
                "datetime": 1791890058,
                "headline": "Thermo Fisher (TMO) Stock Trades Near Fair Value On Digital CMC Launch"
              }
            ],
            "raw_source": [
              {
                "id": 142957868,
                "url": "https://finnhub.io/api/news?id=41edded3ed342441d5de01bda70b447dd724e8160e14a0cd36b2a8a68ebdcc60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology diagnostics, according to recent industry reports. Sector intelligence points to the group as a key provider of targeted omics and biomarker analytics solutions for precision medicine-focused projects. Reports also highlight Thermo Fisher's role in immuno-oncology diagnostic workflows that support more tailored cancer treatment decisions. Thermo Fisher's push into proteomic...",
                "category": "company",
                "datetime": 1792207248,
                "headline": "Thermo Fisher Scientific (TMO) Is Building A Bigger Role In Precision Diagnostics"
              },
              {
                "id": 142950878,
                "url": "https://finnhub.io/api/news?id=01a659179e977f99d551871332a195383d76d25b6bef1ad7ef5128a3afd70cb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific’s fair value estimate has shifted from US$652.85 to US$686.64, pointing to a modestly higher price target in current models. Recent analyst commentary ties this change to more supportive views on Q2 results, sector demand trends and updated company guidance, even as opinions remain split between bullish and more cautious takes. As you read on, you will see how this evolving narrative fits together and what to watch next as new research comes out. Analyst Price Targets...",
                "category": "company",
                "datetime": 1792185336,
                "headline": "Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target Increases"
              },
              {
                "id": 142950011,
                "url": "https://finnhub.io/api/news?id=4ad8f758684d92953fbd2de585f964a4e73e883937172f558367ac5c9e40beba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Coca-Cola, Visa and Mastercard are among the stocks hitting records as investors look beyond the AI trade. Earnings could help broaden the rally.",
                "category": "company",
                "datetime": 1792173180,
                "headline": "Coca-Cola, Visa and Mastercard Hit Records as Investors Rotate Out of Chip Stocks"
              },
              {
                "id": 142949164,
                "url": "https://finnhub.io/api/news?id=f55681fb9d3d7cf02853e043f154ce4908061144fc75cb32d6e25a708e8fb13a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Quantum BioPharma previously announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business for a Phase 2 Lucid-MS trial. Thermo Fisher also rolled out new drug development and cell culture solutions and expanded real-world evidence capabilities across oncology and immunology. Thermo Fisher Scientific now sits at the intersection of rising demand for omics, biomarker analytics, and outsourced clinical research services. This trend concentrates more workflow,...",
                "category": "company",
                "datetime": 1792170722,
                "headline": "Learn Why The Bull Case For Thermo Fisher Scientific Stock Could Change Following Omics Demand Growth"
              },
              {
                "id": 142949165,
                "url": "https://finnhub.io/api/news?id=0e11a1e811c2d8c9b24329817fb7dd1563139d37ba120f270112e4cd46c12d7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Diamond Hill Capital, a First Eagle Investment Management company, issued its Q3 2026 investor letter for its “Large Cap Strategy”. The letter can be downloaded here. The Strategy returned 3.18% (net of fees) in the quarter, outperforming the 2.61% return of the Russell 1000 Value Index. Key positive contributors included stock selection in information technology, an underweight in […]",
                "category": "company",
                "datetime": 1792167090,
                "headline": "Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery"
              },
              {
                "id": 142960652,
                "url": "https://finnhub.io/api/news?id=992e8c04c4ad649e3429a28e5cb40c80192b7a6af54ef7bddcb5c43082bbe30b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/16/Quarterly-Results-Sales-Profits-Earnings.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.",
                "category": "company",
                "datetime": 1792164609,
                "headline": "Lam Research Could Swing $28.6 Billion After Earnings"
              },
              {
                "id": 142948029,
                "url": "https://finnhub.io/api/news?id=b3744e5e387099b071930da9d9246cbd89a20d5f498d066719144ef65eb38e73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q3 2026 investor letter for the “Focused Equity Strategy.” The letter can be downloaded here. The Focused Equity Strategy returned 8.9% gross and 8.7% net in Q3, amid a dynamic investment environment driven by AI infrastructure development. Following an initial […]",
                "category": "company",
                "datetime": 1792164465,
                "headline": "Academic and Government Spending Powers Thermo Fisher (TMO)"
              },
              {
                "id": 142945657,
                "url": "https://finnhub.io/api/news?id=86e42f84449ed54ac215737cb78e9d174bc58dfa04180f23896b357ead3b8403",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Thermo Fisher (TMO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.",
                "category": "company",
                "datetime": 1792152926,
                "headline": "What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings"
              },
              {
                "id": 142945658,
                "url": "https://finnhub.io/api/news?id=5937c8d96e4a29067cbbf1f9f5c835b811df4dde15ff29f986a4607889118814",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1792150201,
                "headline": "If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now"
              },
              {
                "id": 142940598,
                "url": "https://finnhub.io/api/news?id=262b21b1adc1b71fef9fe843b9b682d06e5d7329d37b36a536b81ad53e181907",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- \"Immuno-Oncology Diagnostics. Market Forecasts for Immuno-Oncology Diagnostics by Assay Type, Technology, Client, and Country with Executive/Consultant Guides 2026 to 2030 (4th Edition)\" has been added to ResearchAndMarkets.com's offering. The report highlights the continued expansion of",
                "category": "company",
                "datetime": 1792143780,
                "headline": "Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests"
              },
              {
                "id": 142940599,
                "url": "https://finnhub.io/api/news?id=7569679de9a8cf51e48280b941155d4319a4a8f5ded4e5a539eb8961127abf0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "New 307-page intelligence report maps surging demand for targeted omics technologies, profiling strategic moves by Danaher, Roche, and Thermo Fisher Scientific across global clinical landscapes.Dublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- \"Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product and Place, with Executive and Consultant Guides\" has been added to ResearchAndMarkets.com's offering. Where genomics can’t find all the answers proteomics is stepping up to the pla",
                "category": "company",
                "datetime": 1792140840,
                "headline": "Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery"
              },
              {
                "id": 142944246,
                "url": "https://finnhub.io/api/news?id=31734275923b228cd01cb8f5d4fa2f4d1ea40727bd8b84cfcb8f74f9854d835e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323872517/image_1323872517.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific remains overvalued despite strong Q2/26 results and a 30% stock rally since the last review. I rate the TMO stock a Hold. Read my analysis now.",
                "category": "company",
                "datetime": 1792136749,
                "headline": "Thermo Fisher: Strong Growth, Even Higher Stock Price"
              },
              {
                "id": 142922285,
                "url": "https://finnhub.io/api/news?id=e55ca2d20a0f963b7d205e3befbf4d17eb09a9b24af869bcc4bfcaa8989ea739",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AbbVie, meanwhile, closed just shy of a record high, with shares ticking up 0.6% to $283.40.",
                "category": "company",
                "datetime": 1792096200,
                "headline": "Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear."
              },
              {
                "id": 142916771,
                "url": "https://finnhub.io/api/news?id=5024e7ec675170c0a5a25783ae0feb83a84d769bd02bd60c9b343c091dc26a23",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/15/Franklin---April-21--2024-Pfizer-Site-Ma.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "CNBC Final Trades: Weiss picked 10-year Treasuries, Thomas chose XAR, Firestone favored TMO, and Terranova selected PFE.",
                "category": "company",
                "datetime": 1792050980,
                "headline": "Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’"
              },
              {
                "id": 142906390,
                "url": "https://finnhub.io/api/news?id=5c850fabd074fba949692037137bcd030e692025571a7d5b2b7ed467985abb0f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1728138175/image_1728138175.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools.",
                "category": "company",
                "datetime": 1792040640,
                "headline": "How To Invest In AI Drug Discovery"
              },
              {
                "id": 142919327,
                "url": "https://finnhub.io/api/news?id=65a4c1e7f71a69ddee762fd87637a2cccf490ce8d1cf88d15ddb6d633fa24d07",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.",
                "category": "company",
                "datetime": 1791985800,
                "headline": "Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built"
              },
              {
                "id": 142920081,
                "url": "https://finnhub.io/api/news?id=23fab1a99ee8548665e2ee1e0c5506276de75089410bb4618e15ef8b2a4d6712",
                "image": "https://image.cnbcfm.com/api/v1/image/108409633-1791998483220-1791998313-48998176874-hd.jpg?v=1791998484&w=1920&h=1080",
                "source": "CNBC",
                "related": "TMO",
                "summary": "The Investment Committee gives you their top stocks to watch for the second half.",
                "category": "company",
                "datetime": 1791984093,
                "headline": "Final Trades: Thermo Fisher, Pfizer, U.S. 10-year and the XAR"
              },
              {
                "id": 142885249,
                "url": "https://finnhub.io/api/news?id=57b213eed712c316f4e53ea07da5debb1bd5815da8cff9d3337868093a8277d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1791982813,
                "headline": "Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 142882726,
                "url": "https://finnhub.io/api/news?id=6d31070c906503dc7c4f80416e9c9d62c26a24869010adbea168690095dc58ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791981602,
                "headline": "Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?"
              },
              {
                "id": 142872380,
                "url": "https://finnhub.io/api/news?id=4401f90ee65b7b8c7cf68a6190972a080c7b47a22120ce5180363deb66864b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to reduce tariff and supply-chain risks.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Single-Use Assemblies Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global single-use assemblies market is experiencing rapid growth, driven by expanding biopharmaceutical manufacturing, increased investment in life sciences research and devel",
                "category": "company",
                "datetime": 1791965340,
                "headline": "Single-Use Assemblies Global Market Report 2026-2030 | Capitalize on 22.8% CAGR as Thermo Fisher, Danaher, Sartorius, Merck, and Avantor Scale Modular Bioprocessing"
              },
              {
                "id": 142872381,
                "url": "https://finnhub.io/api/news?id=05a152b22bd6645e86b554f8c69a9b8127736d70f587b17f2d689b239bb084d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"3D Cell Culture Technologies Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global 3D cell culture technologies market is experiencing rapid expansion, supported by growing pharmaceutical research, increased investment in regenerative medicine, and demand for more",
                "category": "company",
                "datetime": 1791965220,
                "headline": "Global 3D Cell Culture Technologies Market Report 2026-2030 | Capitalize on 19.9% CAGR as Merck KGaA, Corning, Thermo Fisher Scientific, Sartorius, and Lonza Scale Organoids"
              },
              {
                "id": 142872383,
                "url": "https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil",
                "category": "company",
                "datetime": 1791965160,
                "headline": "Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"
              },
              {
                "id": 142872384,
                "url": "https://finnhub.io/api/news?id=15d8a08e5fb0ad31cc3bb7dca00b8095176d30fd1740a1de017c0a8ffd497425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI through automated sample prep, AI analytics, high-throughput testing, portfolio expansion via acquisitions, and regional production to reduce tariff exposure.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Flow Cytometry Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global flow cytometry market is experiencing rapid growth, supported by increasing biomedical research, expanding cancer diagnostics, greater availability of advanced cytometers and rising investme",
                "category": "company",
                "datetime": 1791965100,
                "headline": "Global Flow Cytometry Market Report 2026 | Capitalize on 11.3% CAGR as Beckman Coulter, Thermo Fisher, Cytek, and Bio-Rad Scale AI Automation and Precision Medicine"
              },
              {
                "id": 142871496,
                "url": "https://finnhub.io/api/news?id=1a494919336ede16c978937830082d3fb415647bb20d3734ac8ce2f738bbdfdd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Players: Thermo Fisher, IPG Photonics, HORIBA, Roche and Olympus. Profiles cover biophotonics products, market share, segments, trends and opportunities.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Biophotonics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global biophotonics market is experiencing rapid growth as healthcare providers, research institutions and medical device manufacturers increase their use of advanced optical technologies. The market is projected t",
                "category": "company",
                "datetime": 1791964980,
                "headline": "Biophotonics Market Report 2026: Size, Share, Trends, and Forecast to 2030 | Capitalize on AI Imaging and Precision Diagnostics with Thermo Fisher, Philips, ZEISS, and Olympus"
              },
              {
                "id": 142872092,
                "url": "https://finnhub.io/api/news?id=c28b49a0330d1dc4a9ed05d64c56e75f5bea642e98736f86ec65a3eeca271658",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI via automation, contamination control, premium consumables, targeted R&D, strategic acquisitions and localized manufacturing to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Cell Culture Consumables and Equipment Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global cell culture consumables and equipment market is experiencing strong growth as pharmaceutical, biotechnology and academic research organizations expand their work in biologics, vacc",
                "category": "company",
                "datetime": 1791964920,
                "headline": "Global Cell Culture Consumables and Equipment Market Report 2026 | Capitalize on Automation and Cell Therapy as Thermo Fisher, Danaher, Sartorius and Corning Target $25.49B by 2030"
              },
              {
                "id": 142848795,
                "url": "https://finnhub.io/api/news?id=e2aa27bd6760faf5c356ce5abfd9734842cec4cbe5d04868e16d93989348647e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Lindsell Train Ltd, an investment management company, has released its “Lindsell Train Global Equity Fund” third-quarter 2026 investor letter. The letter can be downloaded here. To drive long-term capital growth, the LT Global Equity Fund maintains a concentrated portfolio of developed-market global equities. The Fund fell 1.4% in Q3 2026, trailing the MSCI World Index […]",
                "category": "company",
                "datetime": 1791899665,
                "headline": "Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth"
              },
              {
                "id": 142882290,
                "url": "https://finnhub.io/api/news?id=dad524e982dd6c58bdb1fa3180264aef3534e3fa2d3d927ace66c7ffc4b03f05",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1791898511,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 142851273,
                "url": "https://finnhub.io/api/news?id=89e904f7ec9123e4dd8479b5415fe596d2d08807c1cc886a77c4cd973f5b9ea8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strength.",
                "category": "company",
                "datetime": 1791897900,
                "headline": "Thermo Fisher to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 142882502,
                "url": "https://finnhub.io/api/news?id=eb634c2312a19169e1ad6b8633cad95c8f1778509e8eeb750710445f8ea98323",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Morgan Stanley  analyst Tejas Savant   maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $730.",
                "category": "company",
                "datetime": 1791896362,
                "headline": "Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $730"
              },
              {
                "id": 142848796,
                "url": "https://finnhub.io/api/news?id=75e139aed4770546b0a8239bdcbf52cb2262d5fe8b034413dcc8194c6f4c4553",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Earlier this month, Quantum BioPharma announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to implement a Phase 2 trial of Lucid-MS in progressive multiple sclerosis, while Thermo Fisher also unveiled new drug development, manufacturing, and evidence-generation solutions at CPHI Milan 2026. These developments highlight Thermo Fisher’s widening role across the drug lifecycle, from complex clinical trials to advanced bioprocessing, cell culture media,...",
                "category": "company",
                "datetime": 1791893773,
                "headline": "Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO)"
              },
              {
                "id": 142848797,
                "url": "https://finnhub.io/api/news?id=d8b97ec64552a3689972eaa7a4b082b14408a5c97865f7422bf130bd4d2c1121",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation below historical levels draw investor interest.",
                "category": "company",
                "datetime": 1791893520,
                "headline": "Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?"
              },
              {
                "id": 142882503,
                "url": "https://finnhub.io/api/news?id=bf2cba0472b9e433b5a295712485b0499667c0141fc27249658b8f54e8ffd6b9",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $675 to $760.",
                "category": "company",
                "datetime": 1791892463,
                "headline": "TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760"
              },
              {
                "id": 142847531,
                "url": "https://finnhub.io/api/news?id=5cfb9dfdea22a5616bda9ba5452120ce1fd0d290e0b159c54bde33664ca63ea8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has delivered a solid share price run in recent years, which puts a spotlight on whether the current US$662.24 level lines up with the cash it can generate over time. With fresh partnerships and industry collaborations in play, the key consideration is how much of that future cash flow story is already built into the stock. Thermo Fisher Scientific has returned 36.9% over the past 3 years, so a meaningful part of the long term investment case now hinges on whether...",
                "category": "company",
                "datetime": 1791890058,
                "headline": "Thermo Fisher (TMO) Stock Trades Near Fair Value On Digital CMC Launch"
              },
              {
                "id": 142841701,
                "url": "https://finnhub.io/api/news?id=f4d70637a8a925473c7c6e96451318064d5ab55c9f7165a3b5f46fecc06daa61",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Cell Culture Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global cell culture market is experiencing strong growth, supported by expanding life sciences research, increased academic funding and continued development across the biopharmaceutical industry. The market is projected to rise from $31.25 billion in 2025 to $33.81 billion in 2026, representing a compound annual growth rate (CAGR) of 8.2%. Established use of cell",
                "category": "company",
                "datetime": 1791879120,
                "headline": "Global Cell Culture Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on Biologics and Personalized Medicine with Thermo Fisher, Merck, Lonza and Sartorius"
              },
              {
                "id": 142841702,
                "url": "https://finnhub.io/api/news?id=048f94eeedd8a23075e379daab79f59ab4464f6a0ab20b32513856349eeac805",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Protein Labeling Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global protein labeling market is experiencing rapid expansion, supported by increased investment in proteomics and genomics research, continued advances in labeling technologies, and growing demand for high-performance analytical tools. The market is projected to rise from $2.84 billion in 2025 to $3.13 billion in 2026, representing a compound annual growth ra",
                "category": "company",
                "datetime": 1791879060,
                "headline": "Global Protein Labeling Market Report 2026: Size, Share, Trends, and 2030 Forecast | Capture a $4.89 Billion Market as Thermo Fisher, Merck, Bio-Rad, and Abcam Scale Automation"
              },
              {
                "id": 142840867,
                "url": "https://finnhub.io/api/news?id=c313f877d2b3eece60b7e07734f0845a3f5113c9a1d4ad0b1252ff76e87e365e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Continuous Bioprocessing Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. The global continuous bioprocessing market is experiencing exponential growth as biopharmaceutical manufacturers invest in more efficient, scalable and automated production technologies. The market is projected to increase from $0.38 billion in 2025 to $0.46 billion in 2026, representing a compound annual growth rate (CAGR) of 21.9%. Historical marke",
                "category": "company",
                "datetime": 1791879000,
                "headline": "Continuous Bioprocessing Market 2026: Global Size, Share, Trends, and Forecast to 2030 | Capitalize on 21.5% CAGR with Thermo Fisher, Danaher, Merck KGaA, Sartorius, and Lonza"
              },
              {
                "id": 142840868,
                "url": "https://finnhub.io/api/news?id=7f5119f109fe0a9eb8338385a18b44e5eaab3975df1c4a5a655906a61a893448",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI via partnerships, process intensification, single-use systems, modular bioreactors, efficient purification and capacity expansionDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Industrial Bioprocessing Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. The global industrial bioprocessing market is experiencing strong growth as pharmaceutical manufacturers, biotechnology companies and industrial producers invest in scalable, efficient and sustainable production t",
                "category": "company",
                "datetime": 1791878940,
                "headline": "Global Industrial Bioprocessing Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on 9% CAGR with Thermo Fisher, Danaher, Merck and Sartorius"
              },
              {
                "id": 142839259,
                "url": "https://finnhub.io/api/news?id=0ca2cca795d27730dc247311d3409c103ea81b42c6eef7081ad32f70ace2bc36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Bioprocessing Monitoring Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioprocessing monitoring market is experiencing rapid growth as pharmaceutical manufacturers, biotechnology companies and research laboratories increase their use of real-time process control technologies. The market is projected to grow from $11.55 billion in 2025 to $12.75 billion in 2026, representing a compound annual growth rate (CAGR",
                "category": "company",
                "datetime": 1791878820,
                "headline": "Global Bioprocessing Monitoring Market Report 2026 | Capitalize on $18.63B by 2030 as Thermo Fisher, Danaher, Sartorius and Repligen Accelerate Real-Time PAT"
              },
              {
                "id": 142839260,
                "url": "https://finnhub.io/api/news?id=3825312775661b828b635daf32007d6b458a28a0c73467be0cf8e9b340e8ea52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Bioprocessing Supplies Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioprocessing supplies market is experiencing steady growth as pharmaceutical and biotechnology manufacturers increase production capacity for biologics, biosimilars, vaccines, and other advanced therapies. The market is projected to grow from $10.31 billion in 2025 to $10.73 billion in 2026, representing a compound annual growth rate (CAGR)",
                "category": "company",
                "datetime": 1791878760,
                "headline": "Global Bioprocessing Supplies Market Report 2026: Size, Share, Trends, and Forecast to 2030 | Capitalize on Single-Use Scale with Thermo Fisher, Danaher, Merck, Sartorius"
              },
              {
                "id": 142839262,
                "url": "https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann",
                "category": "company",
                "datetime": 1791878580,
                "headline": "Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"
              },
              {
                "id": 142839263,
                "url": "https://finnhub.io/api/news?id=c8ab2d7c97eb0c2aa408d0fd6bd646b7baf67f5df52eac30687a9e7f74c0a289",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Magneto-DNA Biosensors Market Set to Reach $2.66 Billion by 2030 as Precision Diagnostics AdvanceDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Magneto-Deoxyribonucleic Acid (DNA) Biosensors Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global magneto-deoxyribonucleic acid (DNA) biosensors market is experiencing rapid growth as healthcare systems, research institutions and diagnostic laboratories increase their use of sensitive genetic detection technologies. Th",
                "category": "company",
                "datetime": 1791878520,
                "headline": "Magneto-Deoxyribonucleic Acid (DNA) Biosensors Global Market Report 2026 | Capitalize on 12.9% CAGR and AI Diagnostics with Roche, Thermo Fisher, Siemens Healthineers and Danaher"
              },
              {
                "id": 142839190,
                "url": "https://finnhub.io/api/news?id=c3150ce0191b3fdc0ae0bb0ea632db67ddb5b4db34316d71dff82ae5ce8b94d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Bioconjugation Reagents Market to Reach $3.87 Billion by 2030 as Precision Medicine and Antibody-Drug Conjugate Demand ExpandsDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Bioconjugation Reagents Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioconjugation reagents market is experiencing strong growth, supported by rising pharmaceutical and biotechnology research and development, expanding diagnostic and molecular imaging applications, and increased inve",
                "category": "company",
                "datetime": 1791878520,
                "headline": "Global Bioconjugation Reagents Market Report 2026: Size, Trends, and Forecast to 2030 | Accelerate ADC and Click Chemistry Growth with Thermo Fisher, Merck, Danaher, and Bio-Rad"
              },
              {
                "id": 142822752,
                "url": "https://finnhub.io/api/news?id=86851ce683b67c58f3855b7df249b65633fd8ebd86b57f8ee17c6a85582f8393",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher (TMO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1791817203,
                "headline": "All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy"
              },
              {
                "id": 142819999,
                "url": "https://finnhub.io/api/news?id=c78ba6050df55506200e1e6249798eb8eb2a38d6e4c19c9f0fb8f9596b2be417",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI with AI/ML controls, biosensing, closed-loop processing, DCS, sensors, perfusion, single-use systems, emerging-market expansion and modular pricing.Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- \"Bioprocess Automation Global Market Opportunities and Strategies to 2035\" has been added to ResearchAndMarkets.com's offering. The global bioprocess automation market is experiencing strong growth as biopharmaceutical manufacturers increasingly adopt advanced process control technologies to improve",
                "category": "company",
                "datetime": 1791812940,
                "headline": "Global Bioprocess Automation Market Opportunities and Strategies to 2035 | Capitalize on AI, Perfusion and Single-Use Growth with Thermo Fisher, Danaher, Sartorius and Lonza"
              },
              {
                "id": 142807132,
                "url": "https://finnhub.io/api/news?id=ab85cb453d5792cc1f3fcbd550d3d37f3b07eae51d3d165b3996ab36589fe187",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific, Inc. (NYSE:TMO) is having a good year, with shares surging by over 11% so far. The stock’s outperformance has come as the life-sciences tools market shows signs of recovery. But after the rally, the more important question is whether Thermo Fisher’s earnings growth can justify what investors are now paying for the […]",
                "category": "company",
                "datetime": 1791736373,
                "headline": "Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?"
              },
              {
                "id": 142774378,
                "url": "https://finnhub.io/api/news?id=6ecf61a08d4e89e309d2bc77c13f5e7c620f7c06baba3507c179f7718a35d78e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Get a weekly dividend recap for Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates.",
                "category": "company",
                "datetime": 1791584761,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 11"
              },
              {
                "id": 142766308,
                "url": "https://finnhub.io/api/news?id=c020d3abe82c3115a89a3cc0a2f05b93f15d4411b613658d3758e4376bdb726c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts project a double-digit earnings rise.",
                "category": "company",
                "datetime": 1791551903,
                "headline": "Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect"
              },
              {
                "id": 142732204,
                "url": "https://finnhub.io/api/news?id=0262e7ce775b2d3e6488f59575d6656fdbccfe45a69ee824bf6ddf42b77716ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has helped launch the Digital CMC Consortium to advance digital Chemistry, Manufacturing, and Controls for biopharma. The initiative brings together biopharma companies, technology providers, and regulators to work on shared digital standards for CMC data. The Consortium aims to support faster therapy development, more efficient regulatory reviews, and digital lifecycle management across drug programs. The creation of the Digital CMC Consortium is...",
                "category": "company",
                "datetime": 1791486946,
                "headline": "What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium?"
              },
              {
                "id": 142728921,
                "url": "https://finnhub.io/api/news?id=0dd7d1b383dd91d4ef55e272b4d0e25c1c563ddef68dfa481dcf459a3f0016fa",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.",
                "category": "company",
                "datetime": 1791470101,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 142729887,
                "url": "https://finnhub.io/api/news?id=bac59ef0ea48dc4962e86fe6e7abc5e403a32c6f756e1307fe46f11a5111986b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) just appeared in the headlines after its clinical research business signed a Study Start-Up Agreement with Quantum BioPharma to run a Phase 2 multiple sclerosis trial for Lucid-MS. For context, Thermo Fisher Scientific’s share price is at US$662.06, with a 30-day share price return of 7.87% and a 90-day gain of 26.18%, while the 1-year total shareholder return of 23.91% points to momentum that has been building rather than fading. Capitalize on the momentum...",
                "category": "company",
                "datetime": 1791468482,
                "headline": "Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight"
              },
              {
                "id": 142723365,
                "url": "https://finnhub.io/api/news?id=4d391fdb80c2c3368ea653d29977d894a169ddcb0617a02e031663b3f21c8c17",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Five-year forecasts by application, technology, product and setting, from clinical labs to point of care, as syndromic multiplex panels reshape molecular diagnostics after the pandemic.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- \"PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place Forecasting and Analysis\" has been added to ResearchAndMarkets.com's offering. The pandemic accelerated the adoption of polymerase chain reaction technology and est",
                "category": "company",
                "datetime": 1791456420,
                "headline": "PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher"
              },
              {
                "id": 142720464,
                "url": "https://finnhub.io/api/news?id=53ba34799909d6351483f03741e9578ee3c1ff21e8b25771f85fc62682b2d6f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "230-Page Report Shows How 569,000+ Registered Clinical Studies, CRO Consolidation and AI-Driven Trial Models Are Reshaping Outsourcing Strategy for Pharma and Biotech LeadersDublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- \"Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type, Molecule Type, Services, Therapeutic Area, Region, and Growth Forecasts, 2026-2033\" has been added to ResearchAndMarkets.com's offering. The global pharmaceutical CRO market was valued at an estimated USD 45.33",
                "category": "company",
                "datetime": 1791446760,
                "headline": "Pharmaceutical CRO Market Forecasts Growth from $45.33B (2025) to $83.31B by 2033, Profiling IQVIA, ICON, Thermo Fisher, Medpace & 5 Other Key Players"
              },
              {
                "id": 142699382,
                "url": "https://finnhub.io/api/news?id=9ed3f254690357d4ef7a3ecfc4cdcfbcb1c39c1b9b03a7ddbbca0dd2c87f1e01",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "New agreement moves innovative Lucid-MS treatment from planning into execution. Proprietary platform is designed around a novel neuroprotective approach that targets demyelination rather than solely modulating the immune system. Thermo Fisher's clin...",
                "category": "company",
                "datetime": 1791401400,
                "headline": "Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial"
              },
              {
                "id": 142694861,
                "url": "https://finnhub.io/api/news?id=2ff136808e2f4674b66955885be6cee8df2876307cdfc793a7ae3a9b2b2d314c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher's growth gains momentum through innovation, acquisitions and broad end-market strength, but macroeconomic and currency risks remain.",
                "category": "company",
                "datetime": 1791377100,
                "headline": "Is This the Right Time to Add TMO Stock to Your Portfolio?"
              },
              {
                "id": 142693767,
                "url": "https://finnhub.io/api/news?id=b58fc40ae5e598dea8cde16f52126f564cf1c2ee3879ed84982d201a4a9383d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- \"Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides\" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca",
                "category": "company",
                "datetime": 1791373560,
                "headline": "Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players"
              },
              {
                "id": 142727037,
                "url": "https://finnhub.io/api/news?id=ab05dae09ae89549c7db92012777f3cb2a22f38e2af7fa7272a00ec3b106cec6",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Barclays  analyst Luke Sergott   maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $750.",
                "category": "company",
                "datetime": 1791372652,
                "headline": "Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750"
              },
              {
                "id": 142667710,
                "url": "https://finnhub.io/api/news?id=6f0b4129a65cca5e7460cd8f4162bfc67dd54ec9a4d439adaaf15114ede522d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The bank’s October 2026 focus list adds five stocks that are outside the crowded chip trade.",
                "category": "company",
                "datetime": 1791313980,
                "headline": "JPMorgan reveals stocks worth buying in October 2026"
              },
              {
                "id": 142694485,
                "url": "https://finnhub.io/api/news?id=205ddd44ff6f1452e358342025e56e33cb0dfa365f5e2fbc16991e2a8a53e86d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Golden-Bull-Figurine-In-Foreground-With-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member trades 25% below its own peak.",
                "category": "company",
                "datetime": 1791300578,
                "headline": "The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited"
              },
              {
                "id": 142665620,
                "url": "https://finnhub.io/api/news?id=1b88e839d4e6bdde3abec74c81d424a9665958d9500a5d1c0fc04306bd87ec44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ClearBridge Investments, a global equity manager, recently published third-quarter 2026 commentary for its “Large Cap Growth Strategy”. The letter can be downloaded here. In the third quarter, leadership among large growth stocks shifted from high-momentum semiconductor names to companies with clearer AI monetization paths. The ClearBridge Large Cap Growth Strategy outperformed its Russell 1000 Growth Index […]",
                "category": "company",
                "datetime": 1791296948,
                "headline": "Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook"
              },
              {
                "id": 142658679,
                "url": "https://finnhub.io/api/news?id=2b85dfafb92fc055923365e3024e68096dd6ebe83a76813d3417bd065cfc4122",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Strategic collaboration with leading global contract research organization to implement randomized, double-blind, placebo-controlled Phase 2 study of novel neuroprotective therapyTORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company focused on developing innovative therapies and technologies, today announced that it has entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of T",
                "category": "company",
                "datetime": 1791280800,
                "headline": "Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis"
              },
              {
                "id": 142658104,
                "url": "https://finnhub.io/api/news?id=d71d3039ffe3fa2610c153fe98296ea151fcc3b3383b6bb4436ae637c6076c74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The Digital CMC Consortium today launched as a new industry collaboration uniting biopharmaceutical organizations, biotech firms, CDMOs, technology providers, and consulting experts around a singular goal: the end-to-end digitalization of Chemistry, Manufacturing, and Controls (CMC).",
                "category": "company",
                "datetime": 1791280800,
                "headline": "Biopharma's Leapfrog Moment: The Launch of the Digital CMC Consortium"
              },
              {
                "id": 142657770,
                "url": "https://finnhub.io/api/news?id=1aecdd9fecd03aa9a8c5af9f5e37c699d663f73134c4fbb25f1bc6758036e95b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Quantum BioPharma Ltd. (NASDAQ:QNTM) on Tuesday said it is partnering with the clinical research division of Thermo Fisher Scientific Inc. (NYSE:TMO) to launch a Phase 2 clinical trial for its multiple sclerosis treatment, Lucid-MS. The companies signed a Study Start-Up Agreement, marking a major developmental milestone following the therapy’s recent FDA clearance. Thermo Fisher’s PPD clinical research business will handle the formal study initiation and provide related research services. Read A",
                "category": "company",
                "datetime": 1791280090,
                "headline": "EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial"
              },
              {
                "id": 142649684,
                "url": "https://finnhub.io/api/news?id=66c53becca0f462cd7d8a3204414f2513110733339bf4baae73c3118e209ef63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "MILAN, October 06, 2026--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum. The company will showcase these new and expanded capabilities at CPHI Milan 2026, Oct. 6-8.",
                "category": "company",
                "datetime": 1791266400,
                "headline": "Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026"
              },
              {
                "id": 142648893,
                "url": "https://finnhub.io/api/news?id=edc042f24fdfd21319847f16066a5fa2b9cfe71df6d4e7fb320c4ce8435ecff5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article.",
                "category": "company",
                "datetime": 1791262320,
                "headline": "Zacks Industry Outlook Globus Medical, Intuitive Surgical  and Thermo Fisher Scientific"
              },
              {
                "id": 142635114,
                "url": "https://finnhub.io/api/news?id=942c4f0b7290f5f29d53ab3284d172c7fdfb8a5d18408e3d10222bfc131dea8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., October 05, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its strategic collaboration with Precision Health Research, Singapore (PRECISE) and Nanyang Technological University, Singapore (NTU Singapore) has led to the discovery of more than 2,500 previously unreported genetic-protein associations. By combining Thermo Fisher’s complementary proteomics technologies with PRECISE-SG100K's large-scale health and genomic data, researchers",
                "category": "company",
                "datetime": 1791203400,
                "headline": "Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study"
              },
              {
                "id": 142662629,
                "url": "https://finnhub.io/api/news?id=867732eebdb5f94314143a1eb23bcb39b9c9e617667f66a14b0dacd805550e6a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/05/JPMorgan-headquarters-glass-building-con.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "JPMorgan’s October stock picks spotlight American Express, Liberty Energy and Thermo Fisher, opening ETF plays across value, AI power and health care.",
                "category": "company",
                "datetime": 1791202945,
                "headline": "JPMorgan’s October Stock Picks Hint at 3 ETF Trades: Value, AI Power, Health Care"
              },
              {
                "id": 142635116,
                "url": "https://finnhub.io/api/news?id=f987b82e10c30a2cd67e4bc788910979834699e3ed062c3df727464a3feb5f5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.",
                "category": "company",
                "datetime": 1791202680,
                "headline": "3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes"
              },
              {
                "id": 142663668,
                "url": "https://finnhub.io/api/news?id=32e7e02e782c1eb0ce80f1333fb6748b0e81d602fdfec76538652fa462c09e1f",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.97% on an annualized basis producing an average annual return of 15.7%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1791202535,
                "headline": "Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years"
              },
              {
                "id": 142635068,
                "url": "https://finnhub.io/api/news?id=d7b2c7fb282022bc3e12941ef582df025af31c77426788b23691e29a499cc6d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.",
                "category": "company",
                "datetime": 1791198540,
                "headline": "Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus"
              },
              {
                "id": 142633167,
                "url": "https://finnhub.io/api/news?id=adb9f2f0b1b55601aabcf44f8ff3bf2965b0e51ef0c15b28b0acef4f8ec0c105",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- \"Custom Recombinant Proteins Market - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global custom recombinant proteins market was valued at US$5.3 billion in 2024 and is projected to reach US$10 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.2%. Market growth is supported by rising biopharmaceutical research and development, expanding biologics pipelines, advances in protein engineeri",
                "category": "company",
                "datetime": 1791195300,
                "headline": "Custom Recombinant Proteins Market - Global Strategic Business Report 2026 | Capture the $10 Billion 2030 Shift as Thermo Fisher Scientific, Merck, GenScript, and Sino Biological Redefine Scale"
              },
              {
                "id": 142629913,
                "url": "https://finnhub.io/api/news?id=9600656e234a6fd05b096c5be4a73b3d868b45b1bac63bdb8dd155dda2dd0872",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "JPMorgan adds American Express, Liberty Energy and Thermo Fisher to its October stock picks after a mixed September.",
                "category": "company",
                "datetime": 1791180461,
                "headline": "JPMorgan Adds New Stocks to Its October Favorites List"
              },
              {
                "id": 142588475,
                "url": "https://finnhub.io/api/news?id=6fd48e7304687ae83dfa7d4a7e88d779d862b62a79e75022612c93c7e216a109",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.",
                "category": "company",
                "datetime": 1790943000,
                "headline": "QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel"
              },
              {
                "id": 142559781,
                "url": "https://finnhub.io/api/news?id=8bc692ee0392eb4d7361a1a879fd4534400f026dacfe5cb773e64d483c76f61d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions.Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- \"Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy biomanufacturing market is experiencing rapid expansion as advanced therapies move from research and clinical development toward comm",
                "category": "company",
                "datetime": 1790867340,
                "headline": "Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 as Thermo Fisher Scientific, Merck KGaA, Lonza and Samsung Biologics Accelerate Automation"
              },
              {
                "id": 142546840,
                "url": "https://finnhub.io/api/news?id=2bcc8ac0779ad6e874a3e135d90a4ca6cce8406498c6890643de72a582decaff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q",
                "category": "company",
                "datetime": 1790844120,
                "headline": "Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen"
              },
              {
                "id": 142544883,
                "url": "https://finnhub.io/api/news?id=f2dcb106eb82f0f8650b84ff10a2abbd415f5020ac42211a93c42f7a306833eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global radiation detection, monitoring & safety market is projected to grow from USD 3.80 billion in 2026 to USD 5.68 billion by 2031, at an 8.4% CAGR. Growth is driven by expanding medical imaging and radiotherapy, nuclear energy investments, regulatory requirements, and security concerns. Detection and monitoring products and radiation detectors lead the market, while Asia Pacific is set for significant growth. Key players include Fortive, Thermo Fisher Scientific, Mirion Technologies, Fuj",
                "category": "company",
                "datetime": 1790843340,
                "headline": "Radiation Detection, Monitoring & Safety Market Forecasts Growth from $3.80B (2026) to $5.68B by 2031, Profiling Fortive, Thermo Fisher & Mirion Technologies"
              },
              {
                "id": 142540765,
                "url": "https://finnhub.io/api/news?id=7d6465b472d118677c03014527a5f47cd568772afebdfde05f26b16e70df37cb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1440523601/image_1440523601.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation.",
                "category": "company",
                "datetime": 1790825460,
                "headline": "The Top HealthTech Questions Landing On Our Desks"
              },
              {
                "id": 142517266,
                "url": "https://finnhub.io/api/news?id=8d2449e550c610a33bf877d009c9dcc982c2ef4a8798578f4761789398bd1cdf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities.Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- \"Recombinant Proteins Market - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global recombinant proteins market was valued at US$3.3 billion in 2024 and is projected to reach US$5.8 billion by 2030, expanding at a compound annual growth rate of 10.2%. Ma",
                "category": "company",
                "datetime": 1790775000,
                "headline": "Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption"
              },
              {
                "id": 142512600,
                "url": "https://finnhub.io/api/news?id=8d251d09424e47ffe6afe7ae2fcabc15ca0b3967efdcd06b3fd5a40232055b92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced ProductsDublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- \"Fetal Bovine Serum Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. The global fetal bovine serum market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.3 billion by 2035, expanding",
                "category": "company",
                "datetime": 1790757960,
                "headline": "Fetal Bovine Serum Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Thermo Fisher Scientific, Merck KGaA, and Cytiva"
              },
              {
                "id": 142482867,
                "url": "https://finnhub.io/api/news?id=d91634b5352d5649bd2051f18acf345913d25fd2183ccb0f091e8a105122089b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has been a strong performer over the past year, and that kind of run naturally raises a pointed question for anyone looking at the stock today. Is the current share price aligned with the cash flows the business is expected to generate, or has sentiment moved ahead of the underlying economics? The stock has returned 47.4% over the past year, which puts real pressure on the question of whether the current valuation still lines up with the cash being produced and...",
                "category": "company",
                "datetime": 1790662293,
                "headline": "Thermo Fisher Scientific (TMO) Stock Seems Reasonable Following Its 47% Run"
              },
              {
                "id": 142473985,
                "url": "https://finnhub.io/api/news?id=5f8fe6dff142f268e02e3705b3d9f20cd545fb7e7dc31ec227337cbf85b27784",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "On September 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the launch of the Gibco CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to accelerate cell growth and protein production for CHO-K1 host lines used in biologics and biosimilars development. Offered in liquid and dry powder formats, the ready-to-use catalog panel enables […]",
                "category": "company",
                "datetime": 1790645077,
                "headline": "Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow?"
              },
              {
                "id": 142473986,
                "url": "https://finnhub.io/api/news?id=c10767dd977cb8cd30d03b3e7c6568de4b2729f2722797fcb909af0361e69961",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Earlier this month, Thermo Fisher Scientific announced several product and collaboration updates, including the cGMP-ready Gibco CHO-K1 Catalog Panel for bioprocessing, a reseller agreement to distribute Evosep’s Eno separation platform in proteomics workflows, and expanded involvement in molecular residual disease programs with Biodesix and Memorial Sloan Kettering. Together, these moves deepen Thermo Fisher’s role across biologics manufacturing, advanced proteomics, and ctDNA-based cancer...",
                "category": "company",
                "datetime": 1790644148,
                "headline": "Will Thermo Fisher’s New cGMP CHO-K1 Panel and MRD Moves Change Thermo Fisher Scientific's (TMO) Narrative"
              },
              {
                "id": 142470257,
                "url": "https://finnhub.io/api/news?id=cf5570cdb7032e4ea4fe0efe4335287bed3d60c8fc46c4df6b5504877c967f47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth. Gilead’s momentum is being driven primarily by its HIV portfolio, where established medicines and newer products are expanding rapidly. Thermo Fisher, meanwhile, is beginning to benefit from strengthening customer activity across the life-sciences markets it serves […]",
                "category": "company",
                "datetime": 1790618905,
                "headline": "Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?"
              },
              {
                "id": 142468243,
                "url": "https://finnhub.io/api/news?id=e8d5fd2270a4e1d7c71c061a7e6683e997860a54e7e29568a99ddf4eda6108a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "BDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.",
                "category": "company",
                "datetime": 1790604180,
                "headline": "Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests"
              },
              {
                "id": 142465673,
                "url": "https://finnhub.io/api/news?id=e012d9bf24dcdeb76fd7f66aac9366acdb4a42ec4ce0ced20af65ece740f375b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., September 28, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations.",
                "category": "company",
                "datetime": 1790596800,
                "headline": "Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026"
              },
              {
                "id": 142463237,
                "url": "https://finnhub.io/api/news?id=b8aca1df23d63c98c0172807b4fbb56d2866158c9e2e06dce07b38719fc3e060",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI through standardized QC, auditable automation, validated AI, diversified reagent sourcing, regional partnerships, and cross-skilled workforce trainingDublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- \"Cell Line Generation Market - Global Forecast 2026-2032\" has been added to ResearchAndMarkets.com's offering. This market research report examines the global cell line generation market, which is projected to reach USD 1.42 billion in 2026 and grow at a CAGR of 10.86% to USD 2.67 billion by 2032",
                "category": "company",
                "datetime": 1790586180,
                "headline": "Global Cell Line Generation Market Outlook, 2026-2032 - AI, CRISPR and Automation Fuel 10.86% CAGR, Driving the Market to USD 2.67 Billion as Thermo Fisher Scientific, Lonza, Merck and WuXi Biologics Advance Innovation"
              },
              {
                "id": 142461276,
                "url": "https://finnhub.io/api/news?id=9c96f142188e484f2ef08e9d38f66762c05205d9ad7d5a9f7a65d455fbf9741e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- \"Magnetic Beads - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering. The global magnetic beads market was valued at an estimated US$3.3 billion in 2025 and is projected to reach US$7.4 billion by 2032, advancing at a compound annual growth rate (CAG",
                "category": "company",
                "datetime": 1790582820,
                "headline": "Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership"
              },
              {
                "id": 142462302,
                "url": "https://finnhub.io/api/news?id=076ab45b9e119dacf26b27b8de8743cfc9b3ced268bc9af59c398f5054fcdda8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boost ROI via automated closed handling, resilient sourcing, tailored portfolios, quality-by-design, validated AI, compliance mapping and lifecycle stewardship.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- \"Grignard Reagents Market - Global Forecast 2026-2032\" has been added to ResearchAndMarkets.com's offering. The Grignard Reagents Market research report provides a comprehensive assessment of industry growth, production trends, applications, technologies, and geographic opportunities. The market",
                "category": "company",
                "datetime": 1790582520,
                "headline": "Global Grignard Reagents Market Outlook and Forecast, 2026–2032 - Market to Reach USD 7.87 Billion as Safer, AI-Enabled Production Expands Opportunities for Merck KGaA, Thermo Fisher Scientific, and Tokyo Chemical Industry"
              },
              {
                "id": 142460646,
                "url": "https://finnhub.io/api/news?id=83a1a495198a72ba423d87dc9b98cc3f04e637c1cc30b0bad2a93cee1d638e40",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in standardized proteomics solutions, today announced a reseller agreement with Thermo Fisher Scientific, the world leader in serving science. Through this agreement, Thermo Fisher Scientific will offer the Evosep Eno™ separation platform as part of its portfolio of mass spec",
                "category": "company",
                "datetime": 1790578800,
                "headline": "Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno"
              },
              {
                "id": 142450706,
                "url": "https://finnhub.io/api/news?id=98183ed4127d9a2e12a18ad666f110ff7df16c469d8fd405ff8e7a89bad14d47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different. Thermo Fisher is benefiting from improving activity across life-sciences markets after a prolonged slowdown in pharmaceutical and biotech spending. Pfizer, meanwhile, is trying to rebuild growth around newer medicines as […]",
                "category": "company",
                "datetime": 1790549507,
                "headline": "Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?"
              },
              {
                "id": 142426744,
                "url": "https://finnhub.io/api/news?id=0c3982056f7b14f13a7982cc07fdcca2279f88e48dd6a8c5632bd84d727307d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "A $10,000 holding in Twist Bioscience (TWST) a year ago is worth about $66,600 today. The same sum in the S&P 500 would be worth about $11,700. The company sells made-to-order DNA to drug makers and research labs. Its sales grow fast, but it still loses money. The price now counts on that growth lasting and the losses ending. How much has to go right for that price to hold.",
                "category": "company",
                "datetime": 1790375377,
                "headline": "What Needs To Be True To Buy Twist Bioscience Stock Now?"
              },
              {
                "id": 142422153,
                "url": "https://finnhub.io/api/news?id=e0372d4df206a8be37f5530dd603578bb7e3fe5e62a89bb3e0eae801c7ecff71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1790335802,
                "headline": "Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 142383640,
                "url": "https://finnhub.io/api/news?id=af7721b4a3c3faf40f37a5359500b81eca8d8a2d2c03042a3b8d7aa798c4e476",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. You can download a copy of the letter here. U.S. equities achieved new all-time highs in Q2 2026, driven by a rally in the technology sector, led by memory semiconductor stocks. In Q2 2026, the […]",
                "category": "company",
                "datetime": 1790259567,
                "headline": "Dodge and Cox’s Bullish Stance on Thermo Fisher Scientific (TMO)"
              },
              {
                "id": 142377856,
                "url": "https://finnhub.io/api/news?id=66bfbc06670a60d13954e5695d290adac6a19f1a3561c5de9ad44b4137b0a494",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- \"Cell Isolation/Cell Separation Market - Global Forecast 2026-2032\" has been added to ResearchAndMarkets.com's offering. The market research report examines the global Cell Isolation/Cell Separation Market, which is projected to reach USD 6.97 billion in 2026 and grow a",
                "category": "company",
                "datetime": 1790254800,
                "headline": "Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius"
              },
              {
                "id": 142378130,
                "url": "https://finnhub.io/api/news?id=a6a2698a12e235b7483efb3690526ce2fedb211b659108492c6bf866419ee73a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- \"TDM Reagent Kit Market - Global Forecast 2026-2032\" has been added to ResearchAndMarkets.com's offering. This market research report examines the global TDM Reagent Kit Market, projected to reach USD 2.87 billion in 2026 and grow at a CAGR of 15.84% to USD 6.96 billion",
                "category": "company",
                "datetime": 1790254740,
                "headline": "TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher"
              },
              {
                "id": 142422296,
                "url": "https://finnhub.io/api/news?id=c61b1e2c75215d7cb7e3e9b6b1ffc7d68bc332fa315b744e4a614a054c959fb2",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/24/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher is rising Thursday, hitting an all-time high as strong Q2 results and raised FY guidance continue to support momentum.",
                "category": "company",
                "datetime": 1790250813,
                "headline": "Thermo Fisher Stock Hits Record High: What's Happening?"
              },
              {
                "id": 142374419,
                "url": "https://finnhub.io/api/news?id=b40b200f079fd5d356e0a6c6cb41fd679c1b2be77a4c451cfa80a5c1d65dff85",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Biodesix, Inc. (NASDAQ:BDSX) reported progress in two collaborative Molecular Residual Disease (MRD) monitoring programs designed to detect circulating tumor DNA (ctDNA) in blood following cancer treatment.",
                "category": "company",
                "datetime": 1790246078,
                "headline": "Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher"
              },
              {
                "id": 142374420,
                "url": "https://finnhub.io/api/news?id=cec57ba1d7d7d2aba27f1fdb017e9197cd29cd6b8d3341d83d15f222acb09c3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global medical equipment cooling market is projected to grow from USD 0.68 billion in 2026 to USD 0.84 billion by 2031, at a 4.4% CAGR. Growth is driven by advanced diagnostic, laboratory and life science equipment, rising healthcare investment, biobanking, chronic diseases and smart, energy-efficient cooling. Ultra-low temperature freezers led in 2025, while hospitals and transfusion centers will see significant growth. The US is set to record North America’s highest CAGR, supported by biol",
                "category": "company",
                "datetime": 1790245620,
                "headline": "Medical Equipment Cooling Market Forecasts Growth from $0.63B (2026) to $0.82B by 2031, Profiling Parker Hannifin, Daikin, Thermo Fisher & Boyd Corporation"
              },
              {
                "id": 142374423,
                "url": "https://finnhub.io/api/news?id=6a272da4299dbdd38ecc1f05f9aea0440ad19c5b994b479014c02f7cbb1f1f1d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AI adoption is reshaping medical devices, with ISRG, TEM and TMO leveraging AI to advance precision medicine and drug development.",
                "category": "company",
                "datetime": 1790245320,
                "headline": "Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4"
              },
              {
                "id": 142374421,
                "url": "https://finnhub.io/api/news?id=dca29e061d81a6ea3d2de9b4f9a30dabd7b4b94d2ea64adf2770655c6387eb64",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return of 5.81%, building on a strong 90-day share price return of 31.55% as launches like the Gibco CHO-K1 Catalog Panel feed into a broader pipeline story. Over a longer horizon, the 1-year...",
                "category": "company",
                "datetime": 1790244812,
                "headline": "Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question"
              },
              {
                "id": 142373945,
                "url": "https://finnhub.io/api/news?id=5aaee9d8d295e360721f7259e3d957b0fa58a1a9adfdf3208925e2371900a39b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertiseLOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced strategic progress in two collaborative programs for tumor-informed and tumor-naïve Molecular Residual Disease (MRD) solutions intended to support cancer centers and clinical laboratories. Both solutions detect circulating tum",
                "category": "company",
                "datetime": 1790244000,
                "headline": "Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring"
              },
              {
                "id": 142373829,
                "url": "https://finnhub.io/api/news?id=bd27b9bb9b2b0b268044c23cb8fdac5a578450f4f0403036d33660fc90fa0f5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Oxidative Stress Assay Market Gains Momentum as Chronic Disease Research, Personalized Medicine and Automated High-Throughput Kits Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- \"Oxidative Stress Assay Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Oxidative Stress Assay Market to Reach USD 2.7 Billion by 2035 as Biomarker Testing Expands The global oxidative stress assay market was valued a",
                "category": "company",
                "datetime": 1790237400,
                "headline": "Oxidative Stress Assay Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Merck KGaA, and Abcam"
              },
              {
                "id": 142373830,
                "url": "https://finnhub.io/api/news?id=97948defd59c8e141c81e3c3f6e863499512d8e5b4db02eabe70c90f37573ad3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Reusable Bioreactors Gain Momentum as Biologics, Personalized Therapies and Vaccine Production Drive Automation and Scalable ManufacturingDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- \"Reusable Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Reusable Bioreactors Market to Reach USD 24.7 Billion by 2035 as Biologics Manufacturing Expands The global reusable bioreactors market was valued at US",
                "category": "company",
                "datetime": 1790237340,
                "headline": "Reusable Bioreactors Market Outlook 2026-2035 - Featuring Profiles of Sartorius, Thermo Fisher Scientific, and Cytiva"
              },
              {
                "id": 142373831,
                "url": "https://finnhub.io/api/news?id=abeb6c73028bb85aa12267c94adaf1f41532fe816c00cae69fff4751ea578049",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- \"Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Cell Culture Media Market to Reach USD 10.8 Billion by 2035, Driven by Biopharmaceutical Innovation The global cell culture media market was valued at USD 3.9 billion in 2025 and is",
                "category": "company",
                "datetime": 1790237280,
                "headline": "Cell Culture Media Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Merck KGaA, and Sartorius"
              },
              {
                "id": 142371998,
                "url": "https://finnhub.io/api/news?id=79e4040f0a7e5aa7645dab2d98bb2f426a0cb3c6da47ea807fae49d03441dfaa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CHO-K1 Catalog Panel, a new off the shelf media offering for biologics developers. The panel includes cGMP ready, chemically defined, animal origin free basal and feed media aimed at broad process development and manufacturing use. The new solution is designed to give biologics and biosimilars producers scalable, ready to use options for cell culture performance, productivity, and product quality. The launch of the Gibco CHO-K1...",
                "category": "company",
                "datetime": 1790230469,
                "headline": "Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development"
              },
              {
                "id": 142366269,
                "url": "https://finnhub.io/api/news?id=805ed7f92f05fcd51d42bbe553f9e1bd952d980a27499fb4389f16268e6e486a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/128139629/image_128139629.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Viking Global’s Q2 2026 13F: top holdings, new Ferrari/MSCI stakes, and exits from Apple/Alphabet. See more details here.",
                "category": "company",
                "datetime": 1790195142,
                "headline": "Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2026 Update"
              },
              {
                "id": 142358240,
                "url": "https://finnhub.io/api/news?id=eb3aaabe8da2b4665b078617edd48aca507955364652cd333b2010e3d1f72345",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., September 23, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth and protein production across CHO-K1 cell lines. Available in liquid and dry powder media (DPM) formats, the panel can offer flexible options for process development, scale-up, and manufacturing.",
                "category": "company",
                "datetime": 1790166600,
                "headline": "Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development"
              },
              {
                "id": 142356666,
                "url": "https://finnhub.io/api/news?id=c58aec494eadad86cbe6c488959571345dabf20958cb3b3e229386f3c28a347c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Pharmaceutical Filtration - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Pharmaceutical Filtration was estimated at US$8.0 Billion in 2025 and is projected to reach US$23.4 Billion by 2032, growing at a CAGR of 16.7% f",
                "category": "company",
                "datetime": 1790157360,
                "headline": "Global Pharmaceutical Filtration Report: Biologics Manufacturing Shifts as Danaher, Merck KGaA, Sartorius, 3M and Thermo Fisher Reshape the Market"
              },
              {
                "id": 142356138,
                "url": "https://finnhub.io/api/news?id=27c59eb4e1fc7a6828660b3c7958466dbdfe4cec311a3be419231ad4e6952162",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape BiomanufacturingDublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Bioreactors Market to Reach USD 38.9 Billion by 2035 as Advanced Biomanufacturing Expands The global bioreactors market was valued at USD 13.8 billion in 2025 and is projected to reach",
                "category": "company",
                "datetime": 1790154060,
                "headline": "Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and Danaher"
              },
              {
                "id": 142356139,
                "url": "https://finnhub.io/api/news?id=efce07f891ac6851b042732ade08fdf54e8a3dc815ad750f0e23069ce2659a83",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)\" has been added to ResearchAndMarkets.com's offering.The global Gene Transfer Technologies Market is projected to witness robust growth during the forecast period from 2026 to 2036, driven by the rapid expansion of gene and cell therapies, increasing investments in genomic medicine, and continuous advancements in vector engine",
                "category": "company",
                "datetime": 1790152320,
                "headline": "Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and More"
              },
              {
                "id": 142356140,
                "url": "https://finnhub.io/api/news?id=a08a641cf87ea383446ac016553335b44b762c1023babd10834d03a19c3f6f59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Therapeutic Drug Monitoring - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Therapeutic Drug Monitoring was estimated at US$1.5 Billion in 2025 and is projected to reach US$2.6 Billion by 2032, growing at a CAGR of 8",
                "category": "company",
                "datetime": 1790151060,
                "headline": "Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share"
              },
              {
                "id": 142356141,
                "url": "https://finnhub.io/api/news?id=a260791bca67346a94ec770a4d231c653e330840846dbd4be40d1641943f30ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"In Vivo Toxicology - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for In Vivo Toxicology was estimated at US$4.5 Billion in 2025 and is projected to reach US$6.0 Billion by 2032, growing at a CAGR of 4.3% from 2025 to 2032. This comprehensive re",
                "category": "company",
                "datetime": 1790151000,
                "headline": "Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share"
              },
              {
                "id": 142339965,
                "url": "https://finnhub.io/api/news?id=d1b6e8b524d0647dcaeec0b1a5b6abcaaf33defc75d8f66fc0c8d15a8e837148",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key trends, technologies, segments, regional opportunities and leading companies, in",
                "category": "company",
                "datetime": 1790092440,
                "headline": "NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)"
              },
              {
                "id": 142337771,
                "url": "https://finnhub.io/api/news?id=fb352d79bdc468b0e8febe52db9372e3086bfa7bfe4386043a88dad2d96f6024",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Europe Automated and Closed Cell Therapy Processing Systems Market Size, Share & Industry Analysis Report by Type, Scale, Workflow, Country Outlook and Forecast, 2026-2033\" has been added to ResearchAndMarkets.com's offering. The Europe automated and closed cell therapy pr",
                "category": "company",
                "datetime": 1790083800,
                "headline": "Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza Group"
              },
              {
                "id": 142337741,
                "url": "https://finnhub.io/api/news?id=c5e890bb5c4d9087696cf39fb2fb542426d1fab402fac85d4688fe68cdb68e4c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Alex Bradley told CFO.com how AI is changing the software purchasing process and pulling many finance chiefs further into the buying process.",
                "category": "company",
                "datetime": 1790080591,
                "headline": "G2’s CFO says SaaS expos may become obsolete"
              },
              {
                "id": 142337772,
                "url": "https://finnhub.io/api/news?id=c3dfb9df70ba55ae6e25cbf3d687087518f3e914e7985690f120aabec1f1a2f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Ultima Genomics, a company offering a new architecture to enable ultra-high-throughput, next-generation sequencing, today announced that its UG200™ Ultra Sequencing Platform has been selected to support one of the largest ever human multi-omics biomedical data generation efforts for Precure, LLC, a recently announced initiative led by Mayo Clinic in partnership with Thermo Fisher Scientific.",
                "category": "company",
                "datetime": 1790078400,
                "headline": "Ultima Genomics Selected to Generate One Million-Sample, World-Leading Multi-omic Biomedical Dataset for AI/ML Precure, LLC Initiative"
              },
              {
                "id": 142338460,
                "url": "https://finnhub.io/api/news?id=facc7d733c61312e87f12ef4d694ac2ddb37e0733b8ac0abb04429aa45115ef4",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Moderna--Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.",
                "category": "company",
                "datetime": 1790067421,
                "headline": "Top 3 Health Care Stocks That May Keep You Up At Night This Month"
              },
              {
                "id": 142328475,
                "url": "https://finnhub.io/api/news?id=b8f5142c375749dcd86f165528c6ac8eb46172a6658a4d6afd34853bb9496e20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Aseptic Sampling - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Aseptic Sampling was estimated at US$867.4 Million in 2025 and is projected to reach US$1.3 Billion by 2032, growing at a CAGR of 6.3% from 2025 to 2",
                "category": "company",
                "datetime": 1790065440,
                "headline": "Capitalize on the Aseptic Sampling Shift: Benchmark Merck KGaA, Sartorius, Thermo Fisher Scientific, Danaher and GEA to Secure Bioprocessing ROI Across the Forecast Period"
              },
              {
                "id": 142328486,
                "url": "https://finnhub.io/api/news?id=6d7cd3214f601e11d97056d1fc461efd9175867b221c533ce996c634963f4bbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AI, machine learning and big data are advancing virtual screening and precision medicine, creating opportunities in molecular modeling, docking and data integration.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Drug Discovery Informatics - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discovery Informatics was estimated at US$4.0 Billion in 2025 and is projected to reach US$8.7 Billion by 2032, growing at a CAGR of 11.9% from 2025",
                "category": "company",
                "datetime": 1790065320,
                "headline": "Capitalize on Drug Discovery Informatics: Benchmark Schrödinger, Certara, Dotmatics, Thermo Fisher and BIOVIA to Accelerate R&D ROI and Secure Market Advantage"
              },
              {
                "id": 142328487,
                "url": "https://finnhub.io/api/news?id=293df837bbb17c71cf269b411ac0010b830920bae67dc70e20edcee04009550a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Content Screening (HCS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for High Content Screening (HCS) was valued at US$1.3 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing",
                "category": "company",
                "datetime": 1790065140,
                "headline": "Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue"
              },
              {
                "id": 142328488,
                "url": "https://finnhub.io/api/news?id=bc62eb43c32dce5bfd015e09762d0e8c734bea7afb5cfe2391be8b10ca2ca304",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Demand is rising for faster, accurate ADME-Tox testing, driven by complex biologics, tighter regulation, personalized medicine, and adoption of high-throughput, in vitro and in silico methods.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"ADME-Toxicology Testing - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for ADME-Toxicology Testing was valued at US$10 Billion in 2024 and is projected to reach US$18.8 Billion by 2030, growing at a CAGR o",
                "category": "company",
                "datetime": 1790065080,
                "headline": "Capitalize on the ADME-Toxicology Testing Shift: Benchmark Charles River, Thermo Fisher, Eurofins, WuXi AppTec and Evotec to Accelerate R&D ROI and Outpace Disruption"
              },
              {
                "id": 142328489,
                "url": "https://finnhub.io/api/news?id=324fdbf6440cd650ee257285fca7a92ad2d199002cd24eb6684a7098802aa58d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Throughput Screening (HTS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for High Throughput Screening (HTS) was estimated at US$42.9 Billion in 2024 and is projected to reach US$45.3 Billion by 2030, growing a",
                "category": "company",
                "datetime": 1790065020,
                "headline": "Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI"
              },
              {
                "id": 142315554,
                "url": "https://finnhub.io/api/news?id=cc7729a5c9c66eac16372be163302ad1aa59fce291382b8f18da567361e1480a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher’s 36.4% return over the past six months has outpaced the S&P 500 by 20.1%, and its stock price has climbed to $652.30 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790022625,
                "headline": "3 Reasons to Sell TMO and 1 Stock to Buy Instead"
              },
              {
                "id": 142338992,
                "url": "https://finnhub.io/api/news?id=98636b18fcc6335a2b33bbdaccb77bb211b3929265b32ef892baea54bb203a37",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 5.05% on an annualized basis producing an average annual return of 18.44%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1790006424,
                "headline": "Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today"
              },
              {
                "id": 142311097,
                "url": "https://finnhub.io/api/news?id=549978088471503f39ef8adfc2316186f5ce7fc93dab84136070f50605ea2d73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Market uncertainty persists, but Zacks highlights strong gains across key portfolios and stocks, including PBF, PLTR and ADBE",
                "category": "company",
                "datetime": 1789992600,
                "headline": "Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus"
              },
              {
                "id": 142314367,
                "url": "https://finnhub.io/api/news?id=8845842cf657c6ed4faf7ec765c4297ed1ed51b07a900a7bcab86e444a6c3334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The company will generate population-scale molecular data to inform development of diagnostics, therapies and other healthcare products.",
                "category": "company",
                "datetime": 1789988400,
                "headline": "Mayo Clinic, Thermo Fisher partner to create Precure"
              },
              {
                "id": 142262612,
                "url": "https://finnhub.io/api/news?id=9156ecf7e86c027bc888c338607f18b47e365681f01ac12302bef887f39a6413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]",
                "category": "company",
                "datetime": 1789773304,
                "headline": "Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?"
              },
              {
                "id": 142259687,
                "url": "https://finnhub.io/api/news?id=7c97c539b08be883d006683a58bd2bfb46f6f1895bb3bd738988a2fd58dedb8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among […]",
                "category": "company",
                "datetime": 1789742074,
                "headline": "Thermo Fisher Scientific (TMO) is Positioned for Resurgence"
              },
              {
                "id": 142251285,
                "url": "https://finnhub.io/api/news?id=ef097f4b4ec50f24c759397ae2142a6824f165a87b5f6d19c7bb23913d40a9af",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AI, Advanced Sequencing and Precision Medicine Drive Genomics Opportunities Across Diagnostics, Drug Development and Preventive CareDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- \"Genomics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Genomics Market Forecast to Reach USD 188.7 Billion by 2035, Driven by Precision Healthcare and Sequencing Innovation The global genomics market was valued at USD 44.7 bi",
                "category": "company",
                "datetime": 1789728240,
                "headline": "Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen"
              },
              {
                "id": 142251286,
                "url": "https://finnhub.io/api/news?id=43c1fbec948e57f3e29cfa2fad208abbeda396dc2bca0a297a20b7447014cf1d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Pharmacogenomics Expands as Multi-Gene Testing, Bioinformatics and Precision Diagnostics Drive Clinical AdoptionDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- \"Pharmacogenomics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035\" has been added to ResearchAndMarkets.com's offering. Global Pharmacogenomics Market to Reach USD 15.4 Billion by 2035, Driven by Precision Medicine Adoption The global pharmacogenomics market was valued at USD 5.7 billion in 2025 and is proje",
                "category": "company",
                "datetime": 1789728180,
                "headline": "Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 129,
            "discarded_article_count": 108
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.5,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 2301500,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2266420,
              "avg_vol_20": 2332375,
              "avg_vol_30": 2301500,
              "range_pct_10": 0.09953621739130432,
              "range_pct_20": 0.09953621739130432,
              "range_pct_30": 0.15823186956521734,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9847577666739084,
              "dist_to_20d_high": 0.019886363636363636,
              "down_shrink_days": 0,
              "breakout_level_20d": 704,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6290529061231824
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.8,
            "details": {
              "atrPct": 2.9175942028985506,
              "turnoverUsdM": 1453.485,
              "liquidityPoints": 0.8,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.TMO",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 649.7372,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 5.8,
            "take_profit_price": 739.7246,
            "target_multiplier": 1.9,
            "technical_strength": 1.95,
            "take_profit_percent": 7.2
          },
          "positionPoints": 1.8,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2338933208818066,
          "stopLossPercent": 5.835188405797101,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 20.1314,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.92
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 172.09
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.246
    },
    "kdj": {
      "d": 56.53,
      "j": 91.94,
      "k": 68.33,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 66.05
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 8,
      "trend": "資金入貨",
      "value": 26117500,
      "recentSlope": 609820,
      "previousSlope": 308970
    },
    "rsi": 54.1,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 638.9539,
      "position": "SAR喺價下",
      "distancePct": 7.4,
      "previousTrend": "上升"
    },
    "ma50": 636.689,
    "macd": {
      "macd": 12.428641993871452,
      "trend": "強烈看漲",
      "signal": 11.719135763513489,
      "histogram": 0.7095062303579631
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 668.0878,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 5
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.95,
      "score": 4,
      "avgVolume": 2208725,
      "currentVolume": 2106500
    },
    "derived": {
      "ma20": 668.3455,
      "ma50": 636.689,
      "prevClose": 696.49,
      "avgVolume10": 2310300,
      "avgVolume20": 2208725,
      "changePercent": -0.93,
      "avgVolumeForScore": 2208725
    },
    "ma_cross": {
      "ma20": 668.3455,
      "ma50": 636.689,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 666.418,
      "prevMa50": 634.4894,
      "spreadPct": 4.97,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 643.7393,
      "upper": 692.9517,
      "position": "上半部"
    },
    "rsi_short": 87.27,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.95
    }
  }
}

{
  "close": 690,
  "volume": 2106500,
  "changePercent": -0.93
}